Technical Articles

CD38, originally a multifunctional cell surface molecule and metabolic enzyme, has successfully transformed into a revolutionary target that reshaped the treatment paradigm of multiple myeloma, exemplifying the seamless integration of basic research and clinical translation.

FITC-Labeled CD38 Fc Chimera is a recombinant protein tool that combines the extracellular domain of human CD38 with the Fc fragment of immunoglobulin G (IgG) and is labeled with fluorescein isothiocyanate (FITC). As a specific detection probe for the multifunctional immunomodulatory receptor CD38, it is non-pathogenic but serves as a core experimental reagent in key disease research areas such as multiple myeloma, autoimmune diseases, metabolic disorders, viral infections, and age-related immune decline.